Skip to main content
Features
Assistant
AI grounded in research
Search
Full-text citation search
Collections
Organize and monitor papers
All Features →
Integrations
MCP
Connect AI agents to Scite
API
Programmatic data access
Holdings
Full-text via your library
Zotero Plugin
Citation data in Zotero
Browser Extension
Citation badges anywhere
All Integrations →
Data
Rankings
Pricing
Log In
Start Free Trial
Features
Assistant
AI grounded in research
Search
Full-text citation search
Collections
Organize and monitor papers
All Features →
Integrations
MCP
Connect AI agents to Scite
API
Programmatic data access
Holdings
Full-text via your library
Zotero Plugin
Citation data in Zotero
Browser Extension
Citation badges anywhere
All Integrations →
Data
Rankings
Pricing
Log In
Start Free Trial
Rafael Moreno
Sign up to set email alerts
128
Publications
1,628
Citation Statements Received
3,834
Citation Statements Given
How they've been cited
2,019
39
1,584
5
How they cite others
3,708
191
3,624
19
Affiliations
Institut d'Investigació Biomédica de Bellvitge
,
Institut Català d'Oncologia
Publications
Order By: Most citations
Oncolytic Adenoviral Delivery of an EGFR-Targeting T-cell Engager Improves Antitumor Efficacy
Fajardo
1
,
Guedan
2
,
Rojas
3
et al.
2017
Abstract
Show
157
7
144
0
Get access via publisher
Add to collection
Cite
Targeting the tumor stroma with an oncolytic adenovirus secreting a fibroblast activation protein-targeted bispecific T-cell engager
de Sostoa
1
,
Fajardo
2
,
Moreno
3
et al.
2019
j. immunotherapy cancer
Abstract
Show
158
3
119
0
Get access via publisher
Add to collection
Cite
Safety and Efficacy of VCN-01, an Oncolytic Adenovirus Combining Fiber HSG-Binding Domain Replacement with RGD and Hyaluronidase Expression
Rodríguez-García
1
,
Giménez-Alejandre
2
,
Rojas
3
et al.
2015
Abstract
Show
124
2
104
0
Get access via publisher
Add to collection
Cite
Occupational and environmental scleroderma. Systematic review and meta-analysis
Rubio‐Rivas
1
,
Moreno
2
,
Corbella
3
2017
Clin Rheumatol
Abstract
Show
115
0
83
1
Get access via publisher
Add to collection
Cite
Activation of myeloid and endothelial cells by CD40L gene therapy supports T-cell expansion and migration into the tumor microenvironment
Eriksson
1
,
Moreno
2
,
Milenova
3
et al.
2016
Gene Ther
Abstract
Show
87
1
82
0
Get access via publisher
Add to collection
Cite
Phase I, multicenter, open-label study of intravenous VCN-01 oncolytic adenovirus with or without nab-paclitaxel plus gemcitabine in patients with advanced solid tumors
García‐Carbonero
1
,
Bazán‐Peregrino
2
,
Gil-Martín
3
et al.
2022
J Immunother Cancer
Abstract
Show
101
1
80
1
Get access via publisher
Add to collection
Cite
A Phase 1 Trial of Oncolytic Adenovirus ICOVIR-5 Administered Intravenously to Cutaneous and Uveal Melanoma Patients
García
1
,
Moreno
2
,
Gil-Martín
3
et al.
2019
Human Gene Therapy
Abstract
Show
116
1
81
0
Get access via publisher
Add to collection
Cite
VCN-01 disrupts pancreatic cancer stroma and exerts antitumor effects
Bazán‐Peregrino
1
,
García‐Carbonero
2
,
Laquente
3
et al.
2021
J Immunother Cancer
Abstract
Show
110
0
81
0
Get access via publisher
Add to collection
Cite
1
2
3
4